ZYKIMBRI Trademark

Trademark Overview

On Friday, May 14, 2021, a trademark application was filed for ZYKIMBRI with the United States Patent and Trademark Office. The USPTO has given the ZYKIMBRI trademark a serial number of 90712100. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 22, 2024. This trademark is owned by AbbVie AB. The ZYKIMBRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
zykimbri

General Information

Serial Number90712100
Word MarkZYKIMBRI
Filing DateFriday, May 14, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie AB
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSolna 17154
SE
Party NameAbbVie AB
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSolna 17154
SE

Trademark Events

Event DateEvent Description
Tuesday, May 18, 2021NEW APPLICATION ENTERED
Friday, August 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, September 19, 2021ASSIGNED TO EXAMINER
Sunday, September 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 17, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 17, 2022SOU EXTENSION 1 FILED
Friday, June 17, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022SOU EXTENSION 2 FILED
Wednesday, December 14, 2022SOU EXTENSION 2 GRANTED
Friday, December 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 14, 2023SOU EXTENSION 3 FILED
Wednesday, June 14, 2023SOU EXTENSION 3 GRANTED
Friday, June 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, January 5, 2024PETITION TO REVIVE-GRANTED
Friday, January 5, 2024NOTICE OF REVIVAL - E-MAILED
Friday, January 5, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, January 5, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, December 21, 2023SOU EXTENSION 4 FILED
Wednesday, February 28, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 29, 2024SOU EXTENSION 4 GRANTED
Friday, March 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

zykimbri gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related